SANDRA KRASNOPOLSKY: Open Payments
NPI 1730250242 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 43 payments from 13 companies in 2025. Trend: 2023 $746 · 2024 $452 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $177 |
| Lundbeck LLC | 9 | $137 |
| Axsome Therapeutics, Inc. | 4 | $106 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| ABBVIE INC. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Alkermes, Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $21 |
Products named: REXULTI, Auvelity, INVEGA SUSTENNA, VRAYLAR, SPRAVATO, HETLIOZ, UZEDY, COBENFY.
Industry payments across KY — which companies pay providers there.
